Clinical and laboratory findings from patients with COVID-19 pneumonia in Babol North of Iran: a retrospective cohort study

1. ZHOU P, YANG X-L, WANG X-G, HU B, ZHANG L, ZHANG W, et al. A pneumonia outbreak associated with a new coronavirus of probable bat origin. Nature. 2020; 579:270–310.1038/s41586-020-2012-7Search in Google Scholar

2. LAI C-C, SHIH T-P, KO W-C, TANG H-J, HSUEH P-R. Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) and corona virus disease-2019 (COVID-19): the epidemic and the challenges. Intern J antimicrob agents. 2020; 55:105924.10.1016/j.ijantimicag.2020.105924Search in Google Scholar

3. ORGANIZATION WH. Coronavirus disease 2019 (COVID-19) : situation report, 71. 2020.Search in Google Scholar

4. WU Z, MCGOOGAN JM. Characteristics of and important lessons from the coronavirus disease 2019 (COVID-19) outbreak in China. Jama. 2020.10.1001/jama.2020.2648Search in Google Scholar

5. AI T, YANG Z, HOU H, ZHAN C, CHEN C, LV W, et al. Correlation of chest CT and RT-PCR testing in coronavirus disease 2019 (COVID-19) in China: a report of 1014 cases. Radiology. 2020:200642.10.1148/radiol.2020200642Search in Google Scholar

6. GUO Y-R, CAO Q-D, HONG Z-S, TAN Y-Y, CHEN S-D, JIN H-J, et al. The origin, transmission and clinical therapies on coronavirus disease 2019 (COVID-19) outbreak – an update on the status. Military Med Res. 2020; 7:11.10.1186/s40779-020-00240-0Search in Google Scholar

7. LI Y, XIA L. Coronavirus Disease 2019 (COVID-19): Role of chest CT in diagnosis and management. Am J Roentgenol. 2020:1–7.10.2214/AJR.20.22954Search in Google Scholar

8. CHANG R, SUN W-Z. Repositioning Chloroquine as Ideal Antiviral Prophylactic against COVID-19-Time is Now. Preprints. 2020: 2020030279.10.20944/preprints202003.0279.v1Search in Google Scholar

9. DHAMA K, SHARUN K, TIWARI R, SIRCAR S, BHAT S, MALIK YS, et al. Coronavirus Disease 2019–COVID-19. Preprints. 2020: 2020030001.10.20944/preprints202003.0001.v1Search in Google Scholar

10. ADHIKARI SP, MENG S, WU Y-J, MAO Y-P, YE R-X, WANG Q-Z, et al. Epidemiology, causes, clinical manifestation and diagnosis, prevention and control of coronavirus disease (COVID-19) during the early outbreak period: a scoping review. Infect Dis Poverty. 2020; 9:1–12.10.1186/s40249-020-00646-xSearch in Google Scholar

11. HUANG C, WANG Y, LI X, REN L, ZHAO J, HU Y, et al. Clinical features of patients infected with 2019 novel coronavirus in Wuhan, China. The Lancet. 2020; 395:497–506.10.1016/S0140-6736(20)30183-5Search in Google Scholar

12. WANG D, HU B, HU C, ZHU F, LIU X, ZHANG J, et al. Clinical characteristics of 138 hospitalized patients with 2019 novel coronavirus–infected pneumonia in Wuhan, China. Jama. 2020; 11:1061–69.10.1001/jama.2020.1585Search in Google Scholar

13. LI T. Diagnosis and clinical management of severe acute respiratory syndrome Coronavirus 2 (SARS-CoV-2) infection: an operational recommendation of Peking Union Medical College Hospital (V2. 0) Working Group of 2019 Novel Coronavirus, Peking Union Medical College Hospital. Emerg Microb Infect. 2020; 9:582–5.Search in Google Scholar

14. CHEN N, ZHOU M, DONG X, QU J, GONG F, HAN Y, et al. Epidemiological and clinical characteristics of 99 cases of 2019 novel coronavirus pneumonia in Wuhan, China: a descriptive study. The Lancet. 2020; 395:507–13.10.1016/S0140-6736(20)30211-7Search in Google Scholar

15. ZHOU F, YU T, DU R, FAN G, LIU Y, LIU Z, et al. Clinical course and risk factors for mortality of adult inpatients with COVID-19 in Wuhan, China: a retrospective cohort study. The Lancet. 2020; 395:1054–1062.10.1016/S0140-6736(20)30566-3Search in Google Scholar

16. RUAN Q, YANG K, WANG W, JIANG L, SONG J. Clinical predictors of mortality due to COVID-19 based on an analysis of data of 150 patients from Wuhan, China. Intensive Care Medicine. 2020:1–3.10.1007/s00134-020-05991-xSearch in Google Scholar

17. Yang J, Zheng Y, Gou X, Pu K, Chen Z, Guo Q, et al. Prevalence of comorbidities in the novel Wuhan coronavirus (COVID-19) infection: a systematic review and meta-analysis. Intern J Infect Dis. 2020:1–13.Search in Google Scholar

18. YANG X, YU Y, XU J, SHU H, LIU H, WU Y, et al. Clinical course and outcomes of critically ill patients with SARS-CoV-2 pneumonia in Wuhan, China: a single-centered, retrospective, observational study. The Lancet Respiratory Medicine. 2020.10.1016/S2213-2600(20)30079-5Search in Google Scholar

19. BERMEJO-MARTIN JF, ALMANSA R, MENÉNDEZ R, MENDEZ R, KELVIN DJ, TORRES A. Lymphopenic community acquired pneumonia as signature of severe COVID-19 infection: Lymphopenia in severe COVID-19 infection. J Infect. 2020.10.1016/j.jinf.2020.02.029713366332145214Search in Google Scholar

20. SPROSTON NR, ASHWORTH JJ. Role of C-Reactive Protein at Sites of Inflammation and Infection. Front Immunol. 2018; 9:754.10.3389/fimmu.2018.00754590890129706967Search in Google Scholar

21. LI J, LI S, CAI Y, LIU Q, LI X, ZENG Z, et al. Epidemiological and Clinical Characteristics of 17 Hospitalized Patients with 2019 Novel Coronavirus Infections Outside Wuhan, China. medRxiv. 2020.10.1101/2020.02.11.20022053Search in Google Scholar